MD · Northeast
Baltimore venture capital & startups
Baltimore health, cyber, and applied research commercialization — Johns Hopkins density with thin local fund coverage in our directory.
Baltimore is a research-and-hospital buyer market first: Johns Hopkins clinical and cyber talent, plus state commercialization paths (TEDCO and peers). It is not Washington, DC — adjacency helps federal GTM, but HQ matching and capital patterns differ. Our directory currently anchors on a small set of Baltimore-tied startups; most local seed funds are still coverage gaps.
Include Baltimore city/metro HQ aliases only. Do not treat DC/Arlington fund HQs as Baltimore. Bayesian Health is curated as a Johns Hopkins–associated clinical AI company (HQ commonly cited in Baltimore/Hopkins orbit) even when the hq field is blank.
Venture firms in Baltimore
Matched from fund headquarters in our directory (alias-based). Dual-HQ firms may appear in more than one city.
No fund HQ matches yet for Baltimore. Use the national directory and related reading below.
Startups we cover in Baltimore
Matched from startup hq fields. Many profiles still lack HQ — curated lists in editorial notes fill gaps when verified.
| Startup | One-liner | HQ |
|---|---|---|
| kweliTV | Streaming platform curating films and series from the global Black diaspora. | Baltimore, Maryland |
| Bayesian Health | Clinical AI platform for real-time patient risk stratification and triage in hospitals. | — |
Coverage gaps
-
TEDCO / Maryland Momentum Fund
Primary state commercialization and early checks for Maryland founders; no /fund/ profile yet.
-
Baltimore Angels / Dingman Center Angels
Common first-check networks for local pre-seed; not ingested as directory funds.
-
Catalio Capital Management
Shows up on Hopkins-adjacent biotech/health deals (e.g. Bayesian Health syndicates); not a /fund/ page here.
-
Under Armour / Connected Fitness successors
Historic Baltimore consumer/tech employer signal — not a current startup profile in our set.
Related reading
Baltimore FAQs
Practical answers for founders researching this investor.